Meaning
Administrative regulations within the United States Code of Federal Regulations establish the criteria for electronic records and electronic signatures. Compliance with 21 cfr part 11 ensures that digital submissions are as trustworthy and reliable as paper records in life science and pharmaceutical industries. This rule defines how organizations must maintain system validation and audit trails to prevent data falsification.
Compliance Requirement
System security forms the basis of legal adherence for distributors handling sensitive clinical or production data. Because 21 cfr part 11 dictates the use of unique login credentials and timestamped audit logs, any change to a record becomes a permanent part of the history. Access controls prevent unauthorized modifications and ensure that only trained personnel can interact with the data storage.
This level of oversight is mandatory to maintain the chain of custody for digital assets throughout their lifecycle.
Digital Signature
Legal equivalence between electronic and handwritten signatures depends on specific biometric or non biometric identification methods. Under the framework of 21 cfr part 11, these signatures are linked to their respective records so that they cannot be copied or transferred. No signature is valid without the explicit intent of the signer.
Audit Trail
Secure records preserve the sequence of events from data creation to long term storage. The retention of these logs within 21 cfr part 11 allows inspectors to reconstruct every action taken during the manufacturing or distribution lifecycle. Verification of these trails is a standard part of regulatory audits.
